homefeedbacksupportlog on 20-Jul-2008 
  About F1000

 What is F1000 Biology?
 Key features
 How it's organized
 FAQs
 Faculties and sections
 Scope of sections
 List of Faculty Members
 The evaluation system
 Citing F1000
 Take a tour of the site
 Accessing fulltexts
 PubMed linkout
 How to subscribe
 Academic subscriptions
 Corporate subscriptions
 Try F1000 for free
 Who we are
 Media information
 Librarian resources
 Press releases
 In the press
 Developing countries
 F1000 Medicine
 Terms and conditions
 Privacy policy
 Contact us


Arthur Frankel
Scott & White Clinic in Temple, United States of America

Faculty Member: PHARMACOLOGY & DRUG DISCOVERY > Cancer therapeutics [ since 7 July 2006 ]
[ Evaluations ]
to email [Help]
Evaluations

Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients.
Onda M, Nagata S, …, Hassan R, Pastan I
J Immunol 2006 Dec 15 177(12):8822-34 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Arthur Frankel
Evaluated 16 Jun 2008

Critical role of the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway in recovery from anthrax lethal toxin-induced cell cycle arrest and MEK cleavage in macrophages.
Ha SD, Ng D, Pelech SL, Kim SO
J Biol Chem 2007 Dec 14 282(50):36230-9 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Arthur Frankel
Evaluated 8 Nov 2007

Identification of uPAR-positive chemoresistant cells in small cell lung cancer.
Gutova M, Najbauer J, …, Shih CC, Aboody KS
PLoS ONE 2007 2:e243 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Arthur Frankel
Evaluated 23 Apr 2007

An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.
Smalley KS, Contractor R, …, Meggers E, Herlyn M
Cancer Res 2007 Jan 1 67(1):209-17 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Arthur Frankel
Evaluated 18 Jan 2007

Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases.
Smalley KS, Haass NK, …, Flaherty KT, Herlyn M
Mol Cancer Ther 2006 May 5(5):1136-44 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Michael Weber / Arthur Frankel
Evaluated 18 Jan 2007

Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW, Liu W, …, Mazar AP, Ellis LM
Cancer Res 2005 Sep 1 65(17):7775-81 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Arthur Frankel
Evaluated 17 Aug 2006

^Top  Back to Faculty Members



© 1999-2008 Biology Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info